Pressmeddelanden

PILA PHARMA INVITES TO INVESTOR MEETING IN KOLDING, DENMARK PILA PHARMA AB (publ) (FN STO: PILA) hereby invites local Danish investors to participate in the event we organize together with the regional office of Danish Shareholders Associ...
PILA PHARMA INVITES TO ONLINE INVESTOR MEETING & EARNINGS CALL PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to an online session to discuss and comment the year-end report.
REG MAR
PILA PHARMA publishes year-end report (1 January - 31 December 2023) PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s year-end report for the period January - December 2023. The report can be found on the Company´s website: https...
PILA PHARMA HAS BEEN SELECTED TO PARTICIPATE IN THE REGIONAL SCALE-UP PROGRAM "10 X HEALTH" Pila Pharma and its CEO, Dorte X. Gram, has been selected to participate cost-free in a scale-up program "10 X Health" partially sponsored by the European Regional Development Fu...
REG MAR
Pila Pharma AB announces outcome in the rights issue NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAN...
THE ONGOING RIGHTS ISSUE IN PILA PHARMA HAS ENTERED ITS LAST SUBSCRIPTION WEEK AND WILL END MONDAY 4 DECEMBER. THE LAST DAY OF TRADING SUBSCRIPTION RIGHTS IS WEDNESDAY 29 NOVEMBER Pila Pharma AB (publ) ("Pila Pharma" or the "Company") hereby informs that the subscription period in Company's rights issue of shares that was initiated on 20 November 2023 has...
Visa fler pressmeddelanden

Rapporter

Video

Finansiell kalender

Årsredovisning 2023 Årsredovisning
Årsstämma Årsstämma
Halvårsrapport 2024 Delårsrapport

Om PILA PHARMA

Prenumerera

Få löpande information från PILA PHARMA via e-post.

Handelsinformation

Kurs ()
Förändring ()
Marknad Nasdaq First North Growth Market Kortnamn PILA ISIN-kod SE0015988274 Certified Adviser Aqurat Fondkommission